315 related articles for article (PubMed ID: 22824483)
1. The cardiovascular link to nonalcoholic fatty liver disease: a critical analysis.
Pacana T; Fuchs M
Clin Liver Dis; 2012 Aug; 16(3):599-613. PubMed ID: 22824483
[TBL] [Abstract][Full Text] [Related]
2. [Fatty liver and global cardiometabolic risk].
Szollár L
Orv Hetil; 2010 Nov; 151(47):1946-50. PubMed ID: 21071306
[TBL] [Abstract][Full Text] [Related]
3. [Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of non-alcoholic fatty liver disease to carotid atherosclerosis].
Choi SY; Kim D; Kang JH; Park MJ; Kim YS; Lim SH; Kim CH; Lee HS
Korean J Hepatol; 2008 Mar; 14(1):77-88. PubMed ID: 18367860
[TBL] [Abstract][Full Text] [Related]
4. Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population.
Stepanova M; Younossi ZM
Clin Gastroenterol Hepatol; 2012 Jun; 10(6):646-50. PubMed ID: 22245962
[TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic Fatty liver disease is associated with increased carotid intima-media thickness only in type 2 diabetic subjects with insulin resistance.
Kim SK; Choi YJ; Huh BW; Park SW; Lee EJ; Cho YW; Huh KB
J Clin Endocrinol Metab; 2014 May; 99(5):1879-84. PubMed ID: 24512497
[TBL] [Abstract][Full Text] [Related]
6. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease.
Villanova N; Moscatiello S; Ramilli S; Bugianesi E; Magalotti D; Vanni E; Zoli M; Marchesini G
Hepatology; 2005 Aug; 42(2):473-80. PubMed ID: 15981216
[TBL] [Abstract][Full Text] [Related]
7. Perspective: nonalcoholic fatty liver disease and cardiovascular risk.
Nestel PJ; Mensink RP
Curr Opin Lipidol; 2013 Feb; 24(1):1-3. PubMed ID: 23298957
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology.
Loria P; Marchesini G; Nascimbeni F; Ballestri S; Maurantonio M; Carubbi F; Ratziu V; Lonardo A
Atherosclerosis; 2014 Jan; 232(1):99-109. PubMed ID: 24401223
[TBL] [Abstract][Full Text] [Related]
9. Utility of noninvasive methods for the characterization of nonalcoholic liver steatosis in the family practice. The "VARES" Italian multicenter study.
Grattagliano I; Ubaldi E; Napoli L; Marulli CF; Nebiacolombo C; Cottone C; Portincasa P
Ann Hepatol; 2013; 12(1):70-7. PubMed ID: 23293196
[TBL] [Abstract][Full Text] [Related]
10. [Influence of non-alcoholic fatty liver disease on cardiovascular disease].
Ampuero J; Romero-Gómez M
Gastroenterol Hepatol; 2012 Oct; 35(8):585-93. PubMed ID: 22541252
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?
Asrih M; Jornayvaz FR
Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():55-65. PubMed ID: 25724480
[TBL] [Abstract][Full Text] [Related]
12. The central role of the non alcoholic fatty liver disease in metabolic syndrome.
Hurjui DM; Niţă O; Graur LI; Mihalache L; Popescu DS; Graur M
Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):425-31. PubMed ID: 23077931
[TBL] [Abstract][Full Text] [Related]
13. Nonalcoholic fatty liver disease (NAFLD): a new risk factor for adverse cardiovascular events in dialysis patients.
Mikolasevic I; Racki S; Zaputovic L; Lukenda V; Milic S; Orlic L
Med Hypotheses; 2014 Feb; 82(2):205-8. PubMed ID: 24365277
[TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome.
Targher G; Chonchol M; Miele L; Zoppini G; Pichiri I; Muggeo M
Semin Thromb Hemost; 2009 Apr; 35(3):277-87. PubMed ID: 19452403
[TBL] [Abstract][Full Text] [Related]
15. Vascular Disease in Patients with Nonalcoholic Fatty Liver Disease.
Potze W; Siddiqui MS; Sanyal AJ
Semin Thromb Hemost; 2015 Jul; 41(5):488-93. PubMed ID: 26049073
[TBL] [Abstract][Full Text] [Related]
16. Nonalcoholic fatty liver disease and metabolic syndrome in postmenopausal women.
Rodrigues MH; Bruno AS; Nahas-Neto J; Santos ME; Nahas EA
Gynecol Endocrinol; 2014 May; 30(5):325-9. PubMed ID: 24460502
[TBL] [Abstract][Full Text] [Related]
17. Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps.
Santos RD; Valenti L; Romeo S
Atherosclerosis; 2019 Mar; 282():110-120. PubMed ID: 30731283
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: histological diagnostic criteria and scoring systems.
Tiniakos DG
Eur J Gastroenterol Hepatol; 2010 Jun; 22(6):643-50. PubMed ID: 19478676
[TBL] [Abstract][Full Text] [Related]
19. Association of serum triglyceride-to-HDL cholesterol ratio with carotid artery intima-media thickness, insulin resistance and nonalcoholic fatty liver disease in children and adolescents.
Pacifico L; Bonci E; Andreoli G; Romaggioli S; Di Miscio R; Lombardo CV; Chiesa C
Nutr Metab Cardiovasc Dis; 2014 Jul; 24(7):737-43. PubMed ID: 24656140
[TBL] [Abstract][Full Text] [Related]
20. Obesity and fatty liver are 'grease' for the machinery of hepatic fibrosis.
Bosserhoff A; Hellerbrand C
Dig Dis; 2011; 29(4):377-83. PubMed ID: 21894008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
